A Phase I Clinical Study of ART101 Injection in Healthy Adult Subjects

NCT07529600 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension (HTN)

Interventions

DRUG: Subcutaneous (SC) single dose

Sponsor

Arnatar Therapeutics, Inc.